Jane Street’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
70,395
-32,212
| -31% | -$116K | ﹤0.01% | 4491 |
|
|
2025
Q1 | $307K | Buy |
102,607
+45,716
| +80% | +$137K | ﹤0.01% | 4540 |
|
|
2024
Q4 | $191K | Sell |
56,891
-35,394
| -38% | -$119K | ﹤0.01% | 5118 |
|
|
2024
Q3 | $309K | Sell |
92,285
-2,646
| -3% | -$8.86K | ﹤0.01% | 4826 |
|
|
2024
Q2 | $314K | Buy |
94,931
+50,382
| +113% | +$167K | ﹤0.01% | 4974 |
|
|
2024
Q1 | $180K | Sell |
44,549
-34,194
| -43% | -$138K | ﹤0.01% | 5075 |
|
|
2023
Q4 | $240K | Buy |
78,743
+63,935
| +432% | +$195K | ﹤0.01% | 4852 |
|
|
2023
Q3 | $44.4K | Sell |
14,808
-42,346
| -74% | -$127K | ﹤0.01% | 4786 |
|
|
2023
Q2 | $214K | Sell |
57,154
-60,442
| -51% | -$226K | ﹤0.01% | 4544 |
|
|
2023
Q1 | $394K | Buy |
117,596
+47,342
| +67% | +$159K | ﹤0.01% | 3938 |
|
|
2022
Q4 | $338K | Buy |
70,254
+45,934
| +189% | +$221K | ﹤0.01% | 3828 |
|
|
2022
Q3 | $138K | Buy |
24,320
+5,348
| +28% | +$30.3K | ﹤0.01% | 4769 |
|
|
2022
Q2 | $135K | Sell |
18,972
-94,057
| -83% | -$669K | ﹤0.01% | 4636 |
|
|
2022
Q1 | $816K | Sell |
113,029
-133,887
| -54% | -$967K | ﹤0.01% | 3194 |
|
|
2021
Q4 | $2.21M | Buy |
246,916
+172,550
| +232% | +$1.54M | ﹤0.01% | 1820 |
|
|
2021
Q3 | $2.61M | Buy |
74,366
+59,011
| +384% | +$2.07M | ﹤0.01% | 1552 |
|
|
2021
Q2 | $330K | Buy |
+15,355
| New | +$330K | ﹤0.01% | 3873 |
|